Wegovy: FDA Approves Groundbreaking Heart Disease Prevention Medication

You can read the full story here: Wegovy: FDA Approves Groundbreaking Heart Disease Prevention Medication.
Wegovy Receives FDA Approval as Cardiovascular Disease Prevention Medication The FDA announced on Friday that Wegovy, an injectable semaglutide originally approved for weight loss in certain patients, has now been approved for use as a heart disease prevention medication. This marks a significant development in the field of medical therapy for obesity, as Wegovy becomes … Read more